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The testis presents a special immunological environment, considering its property of
immune privilege that tolerates allo- and auto-antigens. Testicular immune privilege was
once believed to bemainly based on the sequestration of antigens from the immune system
by the blood–testis barrier in the seminiferous epithelium. Substantial evidence supports
the view that the combination of physical structure, testicular cells, and cytokines controls
immune responses in the testis to preserve the structural and functional integrity of tes-
ticular immune privilege. Both systemic immune tolerance and local immunosuppression
help maintain the immune privilege status. Constitutive expression of anti-inﬂammatory
factors in testicular cells is critical for local immunosuppression. However, the testis locally
generates an efﬁcient innate immune system against pathogens. Disruption of thesemech-
anisms may lead to orchitis and impair fertility. This review article highlights the current
understanding of structural, cellular, and molecular mechanisms underlying the unique
immune environment of the testis, particularly its immune privilege status.
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INTRODUCTION
Immune privilege implies a special status of some sites in a mam-
malian body, where allo- and auto-antigens are tolerated (Mellor
andMunn,2006). This phenomenonemergedmore than a century
ago in the eye and the brain of rabbits and rodents during explo-
ration of tumor rejection after transplantation (Simpson, 2006).
Later studies revealed various remarkable immune privilege sites
including the eye, brain, testis, and pregnant uterus.
The testis is a distinct immune privilege site. The concept of
immune privilege in mammals includes two aspects: some tis-
sues induce tolerance after their transplantation to an allogenic
recipient and some tissues readily accept foreign cells without
the induction of immune rejection. The testis exhibits both two
aspects of immune privilege (Fijak and Meinhardt, 2006). A large
number of novel proteins are expressed in developing germ cells
during spermatogenesis. Therefore, sperm production represents
challenges to the immune system since sperms are unique to the
body and appear long after the establishment of immune compe-
tence. However, the testis tolerates these unique antigens. The testis
itself confers protection since auto-antigens induce strong autoim-
mune responses when they are injected elsewhere in the body
(Tung et al., 1981). Initial consideration of the testis as an immune
privileged site was substantiated experimentally when allografts
placed into the interstitial space of the rat testis survived indeﬁ-
nitely (Head et al., 1983). Transplantation of spermatogonial stem
cells into germ cell-depleted testes, even at the interspecies level,
can restore spermatogenesis (Brinster, 2002). Similarly, ectopically
transplanted allogenic testes under the kidney capsule or subderma
of animals resist rejection without systemic immunosuppression
in animals (Kuopio et al., 1989; Ma et al., 2004).
The mechanisms of testicular immune privilege have
been gradually updated based on the progress of numerous
investigations (Fijak et al., 2011). Testicular immune privilege was
initially proposed to be attributed to the absence of lymphatic
drainage until evidence of the existence of afferent lymphatic
vessels in the testis was obtained (Barker and Billingham, 1977).
Subsequently, the sequestration of antigens and antibodies from
the immune system by the blood–testis barrier (BTB) was believed
to play a central role in the maintenance of immune privilege sta-
tus. A growing body of evidence supports the view that systemic
immune tolerance and localized active immunosuppression are
involved in the regulation of testicular immune privilege. There-
fore, multiple mechanisms, including the special structure of
the testis, the immunosuppressive properties of local cells, and
paracrine and endocrine cytokines, could control the immune
privilege of the testis (Meinhardt et al., 1998; Meinhardt and
Hedger, 2011).
STRUCTURAL BASIS OF TESTICULAR IMMUNE PRIVILEGE
The testis is structurally complex regarding the BTB and the many
different cell types it contains. While the testis structure is not fully
responsible for the immune privilege, it is involved partially in the
maintenance of the special testicular immune environment.
STRUCTURE OF THE TESTIS
The structure of the adult mammalian testis is highly organized
and complex consisting of two distinct regions: the seminifer-
ous tubules and the interstitial spaces between tubules (Figure 1).
The testis has two major functions: the generation of sperms
(spermatogenesis), and the synthesis of sex steroid hormones
(steroidogenesis). Spermatogenesis takes place within the semi-
niferous tubules, and steroidogenesis is fulﬁlled by Leydig cells
located in the interstitial spaces. The sex steroid hormones, mainly
testosterone in the testis, are critical for normal spermatogenesis.
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FIGURE 1 | A schematic drawing of micrographs of mammalian
testicular structure and cells. (A)The testis consists of two distinct
regions, namely, seminiferous tubules and interstitial compartments.
(B)Within the seminiferous tubules, the different stages of developing
germ cells are in intimate association with Sertoli cells, forming the
seminiferous epithelium. The blood–testis barrier is formed by junctions
between neighboring Sertoli cells near the basement membrane.
(C) Ampliﬁcation of the interstitial compartment shows cell types. Leydig
cells (Lc) are majority of the interstitial cells. There are various types of
immune cells including mainly macrophages (Mϕ) and minor dendritic cells
(DC), T lymphocytes (T) and mast cells (MC). The blood vessels (BV) exist in
the interstitial compartment.
The seminiferous tubules, which are highly coiled, originate
and terminate at the rete testis. The tubules are surrounded by
myoid peritubular cells (MPCs), which, together with Sertoli
cells (SCs), secrete components of the basement membranes that
enclose the seminiferous epithelium. Columnar SCs extend from
the basal lamina to the lumen of the tubules. These SCs are respon-
sible for physical support of the germ cells, providing them with
essential nutrients and growth factors.
Besides Leydig cells in the testicular interstitial spaces, there
are also blood and lymphatic vessels, as well as various immune
cells including macrophages, mast cells, dendritic cells (DCs),
and lymphocytes (Figure 1). The interstitium represents the ﬁrst
line of testicular defense against pathogens from the bloodstream.
The rete testis, which is a transition zone between the testis and
the epididymitis, is the exit of the testis. The BTB is termi-
nated in the rete testis and spermatozoa are no longer protected
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from autoimmune attacks in the rete testis. Thus, certain forms
of autoimmune orchitis are primarily observed in the rete testis
(Itoh et al., 2005).
BLOOD–TESTIS BARRIER
The BTB is created near the basement membrane by various
junctions including tight junctions (TJs), basal ectoplasanic spe-
cializations, gap junctions, and demosome-like junctions between
two adjacent SCs (Su et al., 2011). The BTB is anatomically
much more complex than other blood–tissue barriers, such as
the blood–brain and blood–retina barriers, which are constructed
exclusively of TJs between endothelial cells. Moreover, the BTB
can be comprised of three components, namely anatomical, phys-
iological, and immunological barriers (Mital et al., 2011). The
junctions that restrict passage of molecules and cells into or
out of the BTB form the anatomical barrier. The physiological
barrier comprises transporters that regulate the passage of sub-
stances, creating a microenvironment for spermatogenesis. The
immunological barrier limits the access of systemic immunity and
sequesters the majority of the auto-antigenic germ cells. A func-
tional BTB relies on the complex interaction between the three
components.
The immune privilege status of the testis was initially believed
to be mainly based on the sequestration of antigens and antibod-
ies by the BTB. This view has been challenged by the observation
that the testicular interstitial spaces, which are located outside
the BTB, are also immune-privileged (Setchell, 1990). Moreover,
although the BTB sequesters most of the auto-antigenic germ
cells in the adluminal compartment of the testis, preleptotene
spermatocytes and spermatogonia located outside the BTB also
express antigenic molecules (Yule et al., 1988). Therefore, the BTB
is partially responsible for the testicular immuneprivilege. A grow-
ing body of evidence shows that the actively immunosuppressive
mechanisms in the testis play important roles in maintaining the
testicular immune privilege status (Meinhardt and Hedger, 2011).
Thus, both the BTB and local immunoregulatory mechanisms
contribute to the testicular immune privilege.
TESTICULAR IMMUNE PRIVILEGE IN DIFFERENT SPECIES
The testicular immune privilege depends on the species. Allo-
grafts and xenografts can survive in the testes of some species,
such as rat and mouse (Head and Billingham, 1985). By con-
trast, similar studies on ram and monkey have not been successful
(Setchell et al., 1995). Moreover, the testes of some species do not
have privilege properties as donor tissues. Mouse testis allografts
under the kidney capsule survive long time (Bellgrau et al., 1995),
but adult rat testes grafted to the kidney were rejected (Statter
et al., 1988). These differences suggest that the factors controlling
testicular immune privilege are variable among species.
An intact testis is not necessary for the immune privilege. In
fact, SCs display an inherent immunosuppressive role that sup-
ports the survival of cells from other tissues, such as pancreatic
islet cells, when they were co-transplanted (Selawry and Cameron,
1993; Suarez-Pinzon et al., 2000). While these previous studies
support that the genetic elements play roles in the maintenance of
testicular immune privilege, some common mechanisms underly-
ing the immune privilege of the testis should be existed in different
species. Notably, the immune privilege of the testis does not
mean the absence of immune responses in this tissue, rather, such
responses are only reduced.
CELLULAR MECHANISMS OF TESTICULAR
IMMUNE PRIVILEGE
The testis is composed of various cell types including immune
cells and testis-speciﬁc cells (Figure 1). Most types of immune
cells, which contain predominantly macrophages, can be found in
the interstitial spaces and are important for maintaining the spe-
cial immunological environment of the testis. Tissue-speciﬁc cell
types include the somatic cells: SCs, Leydig cells, andMPCs, as well
as the different stages of developing germ cells. A growing body of
evidence indicates that the testis-speciﬁc cells exhibit immuno-
logical functions, thus contributing to the testicular immune
privilege.
IMMUNE CELLS IN THE TESTIS
While the testis is a remarkable immune privilege site, it is well
connected to afferent lymph nodes. Therefore, the testis has most
types of immune cells, including macrophages, T lymphocytes,
DCs, and mast cells. These immune cells are important in the
maintenance of the special testicular immune environment.
Macrophages
Macrophages represent a major population among immune cells
in the interstitial space of the testis. Macrophages represent about
20–25% of the interstitial cells of rats under physiological condi-
tions (Hedger, 2002). At least two subsets of macrophages can
be discerned. One of them can be deﬁned by the expression
of a surface antigen that is recognized by antibody ED2, while
the other subset expresses a lysosomal glycoprotein recognized
by antibody ED1. ED2+ macrophages, which are considered to
be resident cells in the testis, represent the majority (∼80%)
of testicular macrophages. ED1+ macrophages, which presum-
ably derive from circulating monocytes/macrophages that have
only recently arrived in the testis, represent a minor (∼20%)
proportion of all testicular macrophages. The balance between
these two macrophage subsets in rats can be disrupted under
orchitis conditions (Breucker, 1978; Rival et al., 2008). Clinical
studies have shown that macrophage numbers are increased in
the testes of patients with aspermatogenesis of different etiologies
(Frungieri et al., 2002a). These observations suggest that testicular
macrophages associate with the immune homeostasis in the testis
and normal spermatogenesis.
Aside from the common features of macrophages in other
organs, testicular macrophages display tissue-speciﬁc functions.
Testicular macrophages, which have close physical interaction
with Leydig cells, show important roles in the development and
steroidogenesis of Leydig cells in adult rats (Gaytan et al., 1994;
Hutson, 2006). Moreover, testicular macrophages also inﬂuence
SC functions and spermatogenesis by producing soluble factors
(Cohen et al., 1999). As a major immune cell population, the
macrophages in the testis are believed to be critical in maintaining
the testicular immune environment, particularly its immune priv-
ilege properties. Testicularmacrophages display a reduced capacity
for producing inﬂammatory factors compared with macrophages
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from other tissues (Kern et al., 1995) and exhibit immunosup-
pressive properties (Kern and Maddocks, 1995), which should
contribute to the maintenance of testicular immune privilege.
However, the two types of testicular macrophages exhibit dif-
ferent immune properties. ED2+ resident macrophages, which are
believed to participate to maintain the immune privilege status
in the testis, do not initiate inﬂammatory responses in LPS-
challenged rats (Gerdprasert et al., 2002b). In contrast, ED1+
macrophages migrate into the testis during acute and chronic
inﬂammation and prominently initiate the inﬂammatory pro-
cess by releasing inﬂammatory cytokines with the potential to
overcome the immune privilege and mount innate immunity to
defense pathogens (Gerdprasert et al., 2002a; Rival et al., 2008).
LPS-induced acute inﬂammation results in only a temporary
inﬂux of new ED1+ macrophages, which can be resolved within
a day or two (Gerdprasert et al., 2002a). In contrast, the increased
number of ED1+ cells is maintained for long periods of time dur-
ing chronic inﬂammation, such as autoimmune orchitis (Theas
et al., 2008). These observations give rise to several important
questions (Fijak and Meinhardt, 2006). What factors are respon-
sible for the recruitment and resolution of ED1+ macrophages
under acute inﬂammatory conditions? What causes the persis-
tent elevated macrophage numbers in the testis with autoimmune
orchitis? What factors regulate the balance of ED1+ inﬂamma-
tory cells and ED2+ resident immunosuppressive macrophages
in the testis under physiologic conditions? The roles of ED1+
macrophages in the pathogenesis of autoimmune orchitis remain
largely unclear.
Dendritic cells
Dendritic cells are bone marrow-derived specialized antigen-
presenting cells (APCs), and induce activation and differentiation
of lymphocytes in response to antigens. DCs not only activate lym-
phocyte responses to allo-antigens but also inhibit autoimmune
responses by tolerating T cells to auto-antigens, thereby mounting
immune responses against invading pathogens and minimizing
the responses to auto-antigens (Banchereau and Steinman, 1998).
DCs represent a minor population (∼1 × 105) of the interstitial
cells in normal rat testis (Sanchez et al., 2006), numbering about
one-tenth of the macrophages (Meinhardt et al., 1998). Since DCs
are the most important immunoregulatory cell types, they could
play roles in regulating testicular immune responses. However,
testicular DCs have not been paid enough attentions because their
minor ratio in the testis. The number of DCs in the testis sig-
niﬁcantly increases in experimental autoimmune orchitis (EAO)
models (Sanchez et al., 2006), suggesting that DCs may participate
in the development of testicular autoimmunity. The mechanisms
underlying the functions of DCs in EAO remain elusive. Various
heat shock proteins (HSPs), including HSP60 and HSP70, which
are abundant in male germ cells, have recently been character-
ized as testicular auto-antigens in EAO (Fijak et al., 2005). They
may initiate the testicularDC-mediated activation of auto-reactive
lymphocytes. HSP70 has been reported to promote APC func-
tion and converts T cell tolerance to autoimmunity in vivo (Millar
et al., 2003). Therefore, the immature DCs, which normally par-
ticipate in maintaining immune privilege, can be hypothesized
to mature by sensing self-antigens, such as HSPs, and mature
DCs may convert immune privilege by the local activation and
expansion of auto-reactive T cells (Fijak et al., 2011). The role
of DCs in regulating the testis immunity is worthy of further
investigation.
Lymphocytes
The testis has afferent lymphatic vessels (Barker and Billingham,
1977). Approximately 15% of the testicular immune cells in adult
rat are T cells with predominantCD8+ cells, whereas B cells are not
found in the normal testis (Hedger and Meinhardt, 2000). Testic-
ular lymphocyte numbers are increased in EAO models (Lustig
et al., 1993) and infertile patients with sperm autoimmunity
(el-Demiry et al., 1987). In EAO, CD4+ and CD8+ cell numbers
dramatically increase at the onset of disease. CD4+ cell numbers
decrease and CD8+ cells remain consistent during disease pro-
gression. These data suggest that CD4+ cells may be involved in
the initiation of the chronic phage of EAO. Interestingly, the two
subsets of lymphocytes contain regulatory T cells (Tregs), which
inhibit antigen-speciﬁc immune responses (Andre et al., 2009).
Studies on pancreatic islet cell allografts in mouse testes shown
that activated T cells are destroyed and graft antigen-speciﬁc Tregs
are produced when they enter the testis environment (Dai et al.,
2005; Nasr et al., 2005). CD4+CD25+ Tregs are critical for periph-
eral tolerance. Tregs may control immune privilege within organs
by preventing autoimmunity induction in regions where antigen-
speciﬁc Tregs continuously encounter tissue antigens (Samy et al.,
2005). This mechanism controls tolerogenic versus autoimmune
response to sperm in vasectomy (Wheeler et al., 2011). Tregs are
found within the testicular interstitium under physiological con-
ditions (Jacobo et al., 2009) and may contribute to the testicular
immune privilege.
Mast cells
Mast cells are another immune cell population with considerable
numbers in the testis. Mast cells in mammalian testis regulate
steroidogenesis by Leydig cells (Aguilar et al., 1995). The increased
mast cell numbers in the testis is associated with male infertility
(Hussein et al., 2005). Mast cells secret serine protease tryptase,
which promotes the proliferation of ﬁbroblasts and synthesis of
collagen (Abe et al., 1998), leading to ﬁbrosis, sclerosis, thickening
hyalinization of tissues, all of which are the features frequently
found in the testis of infertile patients (Apa et al., 2002). Fibro-
sis results in granuloma formation. Mast cells involve in the
granuloma formation in the testis through proteinase-activated
receptor-2 (PAR2) activation. PAR2 is localized to the MPCs,
macrophages, and acrosomes of spermatids in rat testis, and
involved in the development of testicular inﬂammation (Iosub
et al., 2006). PAR2 expression in EAO models is upregulated
and associated with granuloma formation. Mast cells are 10-
fold higher in number and distributed around granulomas in the
testis of EAO compared to normal animals. The mast cells release
tryptases into the interstitial spaces in EAO models, thus activat-
ing PAR2 to induce cell proliferation and cytokine production.
Upregulation of monocyte chemoattractant protein-1 (MCP-1)
could, at least in part, be responsible for the massive inﬁltra-
tion of macrophages into the testis. Similarly, evidence shows
that testicular ﬁbrosis is related to PAR2 activation by mast cells
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(Frungieri et al., 2002b). Most of the studies on the mast cells
focus on their role in regulating testicular inﬂammation. The role
of mast cells in testicular immune privilege remains unknown.
The relatively low number and restricted distribution of mast cells
in the normal testis are believed to be one of mechanisms under-
lying immune privilege. Prevention of mast cell activation may be
a strategy to maintain the immune privilege status of the testis.
TISSUE-SPECIFIC CELLS OF THE TESTIS
Aside from the immune cells, growing evidence shows that
the testis tissue-speciﬁc cells exhibit immunological functions
and contribute to the maintenance of the testicular immune
environment.
Leydig cells
Leydig cells represent the majority of the cell population in the
interstitial compartment of the testis. Leydig cells are critical
endocrine cells that produce androgens for both the seminiferous
tubule compartment to regulate spermatogenesis and peripheral
circulation to extra-testicular androgen-target organs (Diemer
et al., 2003). Several studies have shown that rat Leydig cells exhibit
high antiviral activities in response to viral infections (Dejucq
et al., 1998; Melaine et al., 2003), whereas human Leydig cells dis-
play relatively weak antiviral abilities (Le Tortorec et al., 2008). The
mechanisms of Leydig cell-initiated antiviral responses remain
elusive.
Leydig cells may also regulate testicular immunity through
affecting the immune cell functions. It has been known that Leydig
cells regulate the expansion of testicular macrophages and lym-
phocyte numbers in the testis (Raburn et al., 1993; Hedger and
Meinhardt,2000). Androgenshave immunosuppressive roles, con-
tributing to the immunological differences between sexes (Cutolo
et al., 2004). A blockade of androgen production in Leydig cell
rapidly rejects intratesticular allografts, suggesting the role of
androgens in regulating immune privilege (Head and Billingham,
1985). The intratesticular testosterone concentration is 10-fold
higher than the serum concentration far greater than necessary for
the maintenance of normal spermatogenesis (Jarow et al., 2005).
The high local testosterone concentration is likely involved in the
maintenance of the testicular immune privilege. Testosterones
seem to play immunosuppressive functions by regulating the bal-
ance between pro- and anti-inﬂammatory cytokine expression in
SCs, Leydig cells, and MPCs, but they should not directly affect
testicular leukocytes since androgen receptors have not been found
in testicular immune cells. The role of testosterones in regu-
lating testicular immune responses is worthwhile to be further
investigated.
Myoid peritubular cells
Myoid peritubular cells surround the seminiferous tubules, and
build a wall supporting the integrity of the tubules (Figure 1).
MPCs contain contractile elements that help transport the
immotile spermatozoa into the epididymis (Maekawa et al., 1996).
MPCs secrete the components of the basal lamina that enclose
the contents of the seminiferous epithelium. Several layers of
MPCs build the walls of the tubules in human males, whereas
only one layer of MPCs in rodents. The functions of MPCs in
regulating spermatogenesis are largely unexplored. Previous stud-
ies have shown that MPCs can directly, or more likely indirectly,
regulate spermatogenesis and testis development via secreted fac-
tors (Verhoeven et al., 2000). A recent study indicated that MPCs
express androgen receptors and mediate androgen actions on fetal
SC proliferation (Scott et al., 2007). Based on their localization and
structure, MPCs are believed to participate in the maintenance of
the testicular immune environment. A role of MPCs in testicu-
lar inﬂammation has emerged, especially in EAO (Schuppe and
Meinhardt, 2005). MPCs release a number of cytokines, including
transforming growth factor β-2 (TGFβ-2), MCP-1, and leukemia
inhibitory factor. MCP-1 should, at least in part, account for the
recruitment of inﬂammatory monocytes and/or macrophages to
inﬂame the testis. Human MPCs express TNF-α receptors 1 and
2, which mediate the expression of other inﬂammatory molecules,
including IL-6 and COX-2 (Schell et al., 2008). The roles of
MPCs in the testicular inﬂammatory responses must be further
clariﬁed.
Sertoli cells
Sertoli cells are only somatic cells within the seminiferous tubules
and acquire a columnar sharp extending from the basal lamina
toward the lumen of the tubules (Figure 1). SCs constitute the
main structural element of the seminiferous epithelium and are
responsible for the physical support of germ cells, aside from pro-
viding essential nutrients and growth factors. Moreover, immune
activities of SCs in the testis are emerging.
Sertoli cells were recognized to have immunosuppressive activ-
ities two decades ago (Wyatt et al., 1988; De Cesaris et al., 1992).
They are able to provide an immunoprotective environment for
some allografts and xenografts in co-transplantation experiments
(Sanberg et al., 1996; Suarez-Pinzon et al., 2000). This immuno-
protective environment can not be due to the physical barrier
formed by SCs in the testis, rather, it seems to be provided by the
inherent properties of the cells. Factors secreted by SCs, and the
molecules expressed on their surfaces are most likely participated
in the immunoprotection of SCs. Molecule mechanisms underly-
ing the immunological functions of SCs will be discussed in late
sections of this review.
More than half of all developing germ cells undergo apoptosis
during spermatogenesis, and the cytoplasmic portions of elon-
gated spermatids are shed and form residual bodies in the last stage
of spermatogenesis. Phagocyte removal of the apoptotic germ cells
and residual bodies by SCs are critical for healthy germ cells to pro-
ceed through spermatogenesis. The importance of removal of the
apoptotic cells and residual bodies for normal spermatogenesis
can be hypothesized as follows (Nakanishi and Shiratsuchi, 2004):
(1) elimination of apoptotic cells provides appropriate space in the
seminiferous epithelium for normal spermatogenesis; (2) apop-
totic cells and residual bodies must be removed prior to secondary
necrosis that may release noxious contents for healthy cells; and
(3) the uptake of residual bodies and apoptosis cells endows SCs
into producing factors necessary for spermatogenesis. However,
direct evidence showing the meaning of phagocytic removal of
apoptotic cells and residual bodies by SCs is still missing.
Phagocytosis is a fundamental cellular process that serves mul-
tiple functions in immunity (Greenberg and Grinstein, 2002).
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The signiﬁcance of phagocytic removal of apoptotic germ cells
by SCs in maintaining testicular immune environment has not
been revealed. Growing evidence shows that endogenous Toll-like
receptor (TLR) ligands released fromdamaged tissues andnecrotic
cells can induce non-infectious inﬂammation through TLR acti-
vation (Piccinini and Midwood, 2010). Numerous endogenous
TLR ligands high-mobility group box1 (HMGB1) and different
HSPs have been identiﬁed (Vabulas et al., 2001; Curtin et al., 2009;
Wheeler et al., 2009). HMGB1 and HSPs are abundantly expressed
inmale germ cells (Biggiogera et al., 1996; Zetterstromet al., 2006).
Therefore, one can hypothesize that necrotic germ cells and bro-
ken down residual bodies under some pathological conditions
may release endogenous TLR ligands, inducing non-infectious
inﬂammation. This hypothesis is agreement with the previous
observations that physical trauma and chemical noxae, which
induce germ cell apoptosis, associate with chronic testicular orchi-
tis (Schuppe et al., 2008). A recent study showed that an impaired
removal of apoptotic germ cells induce non-infectious testicular
inﬂammation, thus favoring autoimmunity in the testis (Schuppe
et al., 2008; Pelletier et al., 2009). The meaning of phagocytic
removal of apoptotic germ cells by SCs in maintaining testic-
ular immune environment should be an interesting topic to be
investigated.
Germ cells
Sperm production is a major function of the testis, and develop-
ing germ cells represent the majority of testicular cells. However,
the roles of germ cells in regulating testicular immune environ-
ment have yet to be extensively investigated. Previous studies
demonstrated that male germ cells secrete various inﬂamma-
tory cytokines, including IL-1α (Haugen et al., 1994) and TNF-α
(De et al., 1993). Moreover, spermatogonia produce antiviral
proteins in response to interferon (IFN)-α and IFN-γ (Melaine
et al., 2003). In physiology, these cytokines may play roles in
controlling the efﬁciency of spermatogenesis by inhibiting germ
cell apoptosis (Pentikainen et al., 2001). In pathology, inﬂam-
matory cytokines are up-regulated in the testis of EAO models
and impair spermatogenesis through stimulation of inﬂamma-
tion and induction of germ cell apoptosis (Rival et al., 2006;
Theas et al., 2008).
Most intriguingly, Fas ligand (FasL) is abundantly expressed in
the meiotic and post-meiotic germ cells (D’Alessio et al., 2001).
FasL-expressing cells may contribute to immune privilege by
inducing apoptosis of Fas-bearing lymphocytes (Suda et al., 1993).
Recent studies have revealed that some stages of spermatogenic
cells express TLRs, which will be discussed in a late section of this
paper. The role of male germ cells in maintaining the special tes-
ticular immune environment is emerging, and worthy of further
investigation.
MOLECULAR ASPECTS OF TESTICULAR IMMUNE PRIVILEGE
The testicular cells express and secret numerous immunoregula-
tory molecules that play important roles in regulating immune
responses in the testis (Figure 2). Various immunosuppres-
sive molecules, such as androgens, programmed death ligand-1
(PD-L1), FasL, growth arrest-speciﬁc gene product 6 (Gas6), and
protein S (ProS) are produced by testicular cells. To overcome
immune privilege, the testis must mount appropriate local
innate response against invading pathogens. TLRs in testicular
cells play important roles in initiating testicular innate immune
responses.
EFFECT OF HORMONES ON THE TESTICULAR IMMUNE RESPONSES
Macrophages and Leydig cells represent major immune and
endocrine cells in the interstitial spaces, these two cell populations
regulate each other’s development (Hedger, 2002). Luteinizing
hormone may control macrophage expansion in the testis dur-
ing puberty and maintenance of macrophages in the adult testis
by acting on Leydig cells (Raburn et al., 1993). Evidence shows
that follicle-stimulating hormone regulates maturation of testic-
ular macrophages via SCs (Duckett et al., 1997). Moreover, the
testicular endocrine environment can affect other type of immune
cells in the testis (Hedger and Meinhardt, 2000). The immune cells
in the testis should be regulated by the function of a mature testis,
rather than the direct effects of the hormones on the immune cells
that lack hormone receptors (Meinhardt and Hedger, 2011).
Production of androgens (mainly testosterone) is a major
function of Leydig cells. Androgens exhibit immunosuppressive
activities that contribute to different immune responses between
the sexes (Cutolo et al., 2004). Testosterone reduces TLR4 expres-
sion in macrophages (Rettew et al., 2008). Administration of
testosterone suppresses autoimmune diseases (Cutolo, 2009; Gold
and Voskuhl, 2009). Accordingly, gonadotropin-releasing hor-
mone antagonists signiﬁcantly reduce the percentage of Treg cells,
and increase the proportion of NK cells in human males (Page
et al., 2006). These data suggest that androgens play roles in
maintaining the balance between autoimmunity and tolerance.
Substantial evidence of the link between androgens and testic-
ular immune privilege was found in investigations using mice
conditional knockout androgen receptors in SCs. SC-speciﬁc
deletion of the androgen receptor in mice disrupts testicular
immune privilege (Meng et al., 2011), possibly because andro-
gens regulate SC TJs (McCabe et al., 2010). In agreement with
these the data above, an earlier study indicated that andro-
gens regulate the permeability of the BTB by regulating the
expression of a SC TJ protein, CLDN3 (Meng et al., 2005).
Taken together, androgens play critical roles in maintaining
the integrity of testicular immune privilege by regulating local
microenvironments.
Fas/FasL SYSTEM
FasL-induced lymphocyte apoptosis was once thought as a criti-
cal mechanism underlying the testicular immune privilege. This
concept was contradicted by different studies. FasL suppresses
immune responses by inducing apoptosis of Fas-bearing activated
lymphocytes (Dhein et al., 1995). The testis is a major source of
FasL mRNA in rodents (Suda et al., 1993), and the Fas/FasL system
was demonstrated to be important in themaintenance of testicular
immune privilege based on observations that SCs expressing FasL
induce apoptosis of Fas-bearing lymphocytes (Bellgrau et al., 1995;
Takeda et al., 1998; Figure 2). This conclusion was challenged
by other studies. Genetically modiﬁed islets expressing FasL did
not protect the islets from immune rejection (Allison et al., 1997).
Neutralizing antibodies against FasL did not signiﬁcantly reduce
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FIGURE 2 | A schematic drawing illustrating intercellular communication
via paracrine immunosuppressive molecules that favor immune
privilege in the testis. Under the inﬂuence of follicle-stimulating hormone
(FSH), androgens and germ cell antigens, Sertoli cells secrete
immunosuppressive molecules that inhibit inﬂammatory responses of
macrophages andT lymphocytes (T) in the interstitial compartments.
Sertoli, Leydig cells and macrophages regulate activities of the other
immune cells including dendritic cells (DC), T and mast cells (MC) via
paracrine immunosuppressive molecules, favoring testicular immune
privilege property.
the survival of islets in non-obese diabetic mice that received
co-grafts of SCs and islets (Korbutt et al., 2000).
In fact, convincing evidence showed that testicular FasL is
expressed not in SCs but in meiotic and post-meiotic germ cells
(D’Alessio et al., 2001). However, it remains to be clariﬁed whether
the germcells expressing FasL contribute to the immuneprivileged
status within the seminiferous tubules. Discrepant distribution of
FasL as indicated in these previous studies might be caused by cell
contamination and usage of non-speciﬁc antibodies. The involve-
ment of Fas/FasL in the immunosuppressive properties of SCs
should be reconsidered.
LOCAL IMMUNOSUPPRESSIVE MILIEU
While the role of Fas/FasL system in maintaining the testicular
immune privilege has been in doubt, other immunosuppressive
molecules have been demonstrated to play roles in suppressing
immune responses in the testis. A recent study shows that
lyso-glycerophosphatidylcholines (lyso-GPCs) in interstitial ﬂuid
inhibit T cell activity, contributing to testicular immunosuppres-
sion (Foulds et al., 2008). However, the mechanisms underlying
the lyso-GPC-mediated immune suppression remainunclear. Pro-
grammed death receptor-1 (PD-1) is a transmembrane protein,
and PD-L1 (also named B7-H1) is a functional ligand of PD-1.
PD-1 is expressed in T cells, and its activation by PD-L1 mediates
T cell tolerance (Keir et al., 2006). A recent study demonstrated
that PD-L1 is constitutively expressed in the testis and contributes
to the long-term survival of islet allografts transplanted in the
testis, suggesting that the PD-1/PD-L1 system may contribute to
testicular immune privilege (Cheng et al., 2009).
Another attention deserves to be paid to the role of Gas6/ProS-
TAM system in maintaining testicular immune environment.
TAM receptors are the latest identiﬁed subfamily of receptor
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tyrosine kinases, which include three members, namely, Tyro3,
Axl and Mer (TAM; Haﬁzi and Dahlback, 2006). Two close rel-
ative vitamin K-dependent proteins, the product of Gas6 and
ProS (a blood anticoagulant cofactor), are biological ligands of
TAM receptors (Haﬁzi and Dahlback, 2006). TAM triple knock-
out mice are male infertile due to progressive loss of germ cells
(Lu et al., 1999; Chen et al., 2009). Gene targeting mutation stud-
ies have shown that TAM receptors are essential regulators of
the immune homeostasis by regulating negatively TLR-initiated
innate immune responses in DCs and macrophages (Rothlin et al.,
2007; Lemke and Rothlin, 2008). We previously demonstrated
that TAM receptors are abundantly expressed in mouse SCs and
Leydig cells, whereas Gas6 and ProS are prominently expressed
in Leydig cells (Wang et al., 2005). We also provided recently
evidence that TAM signaling suppresses TLR-initiated testicular
innate immune responses in SCs and Leydig cells (Sun et al., 2010;
Shang et al., 2011). Based on these ﬁndings, we speculate that
the Gas6/TAM system may be critical in regulating the immune
privileged status of the testis. It is worthwhile to investigate this
possibility.
TLR-INITIATED TESTICULAR INNATE IMMUNE RESPONSES
An immune privileged status does not indicate that the site has no
effective immune response. Actually, the testis tolerates invading
antigens. TLR-mediated innate immune responses in testicu-
lar cells play a critical role in the protection of the testis from
infections.
Toll-like receptors are pattern recognition receptors that rec-
ognize pathogen-associated molecular patterns (PAMPs). The
activation of TLRs by PAMPs represents one of the most impor-
tant mechanisms of immune responses against pathogens (Takeda
and Akira, 2005). TLRs can be also recognized and activated by
endogenous ligands that can be released from damaged tissues
and necrotic cells, which are termed damage-associated molecular
patterns (DAMPs; Seong and Matzinger, 2004). The expression
and signiﬁcance of TLRs in the testicular functions have recently
been recognized (Hedger, 2011). Various TLRs are expressed in
the testis of different species including humans (Fujita et al., 2011)
and murines (Bhushan et al., 2008). Most studies on TLR func-
tions in the testis have been performed using murine models.
Recent studies demonstrated that mouse SCs express functional
TLR2 to TLR6 (Riccioli et al., 2006; Starace et al., 2008; Wu et al.,
2008), which were conﬁrmed in rat SCs (Bhushan et al., 2008;
Winnall et al., 2011). Using isolated testicular cells, we also demon-
strated in vitro that TLR3 and TLR4 in mouse Leydig cells, and
TLR3 in spermatogenic cells trigger innate immunity in response
to ligand stimulation (Shang et al., 2011; Tao et al., 2012). TLR2
and TLR4 were observed in human sperms, and responded to
bacterial endotoxins (Fujita et al., 2011). The observations imply
that TLRs in non-immune testicular cells may play important
roles for the testis to mount appropriate local innate immune
responses to invading microbial pathogens. Notably, SCs are rel-
atively less sensitive to ultra-pure LPS or Poly(I:C) compared
with macrophages based on the expression levels of inﬂamma-
tory cytokines, although both cell types express comparable levels
of TLR3 and TLR4. Inhibitory effect of Gas6/ProS-TAM sys-
tem on TLR signaling in both SCs and Leydig cells should be
responsible, at least in part, for the less sensitive to TLR stim-
ulation. Therefore, the interplay of TLRs and TAM receptors
could be important in the maintenance of immunological bal-
ance in the testis. We are collecting more evidence to conﬁrm this
hypothesis. It should be note that most of the studies on expres-
sion and function of TLRs in the testicular cells are performed
in vitro using primary cells and puriﬁed ligands. Role of TLRs in
defense against invading pathogens in the testis should be con-
ﬁrmed in vivo when animals are infected with microbes using TLR
knockout mice.
PARACRINE AND ENDOCRINE CYTOKINE REGULATION OF
TESTICULAR INFLAMMATION
Numerous paracrine and autocrine cytokines in the testis are criti-
cal for normal testicular functions. Most of these cytokines belong
to immunoregulatory factors including those with immunosup-
pressive or pro-inﬂammatory activities, such as TGF-β family
(Avallet et al., 1994; O’Bryan et al., 2005). TGF-βs contribute to
testicular immune privilege through their immunosuppressive
activities (Pollanen et al., 1993). TGF-β1 facilitates SCs to support
graft survival in co-transplantation experiments (Suarez-Pinzon
et al., 2000).
Major pro-inﬂammatory factors, including IL-1, IL-6, and
TNF-α, are expressed in the testis and regulate testicular functions
under physiological conditions. IL-1 is an important mediator
of inﬂammation in the testis. A recent study showed that IL-1α
facilitates BTB opening by affecting the actin cytoskeleton (Sarkar
et al., 2008). IL-1β is feebly produced by the testis under physio-
logical conditions. However, an upregulation of IL-1β has been
observed under inﬂammatory conditions in the testis, which
may be harmful to spermatogenesis (Guazzone et al., 2009). IL-6
promotes potently inﬂammatory events via the expansion and
activation of T cells. Most testicular cells, including somatic
cells and germ cells in normal rats, produce IL-6 (Potashnik
et al., 2005). IL-6 production is upregulated in LPS-induced acute
testicular inﬂammation model. Moreover, IL-6 expression in tes-
ticular macrophages is signiﬁcantly increased in EAO (Rival et al.,
2006). Circulating monocytes (ED1+) that arrive at the testis
notably express IL-6 at high levels compared with resident tes-
ticular macrophages (ED2+), suggesting the distinct roles of the
two types of macrophages in mediating inﬂammatory responses.
An in vitro study has shown that exogenous IL-6 induces germ cell
apoptosis (Theas et al., 2003). TNF-α is the most potent proin-
ﬂammatory cytokine. TNF-α is prominently synthesized by germ
cells within normal seminiferous tubules (De et al., 1993). Vari-
ous types of interstitial cells, such as macrophages and mast cells,
synthesize TNF-α (Xiong and Hales, 1993). TNF-α protects germ
cells from apoptosis at a physiologically low concentrations in
normal testes. In oppositely, TNF-α behaves as an apoptotic fac-
tor that induces germ cell death under inﬂammatory conditions
(Theas et al., 2008). These three pro-inﬂammatory cytokines can
be induced by TLR activation in testicular cells, including SCs,
Leydig, and germ cells. Moreover, antiviral cytokines including
IFN-α, -β are produced by these testis-speciﬁc cells through TLR
activation (Wuet al., 2008; Sun et al., 2010; Shang et al., 2011;Wang
et al., 2012). These cytokines could participate in the host defense
against pathogens through the regulation of immune responses
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or the direct killing of invading pathogens in vivo. They may also
impair spermatogenesis under the inﬂammatory conditions.
Various chemokines may regulate immune responses in the
testis. Chemokines are a large family of small cytokines with
chemoattractive activities. They can be grouped into the two
major subfamilies, namely, CC ligands (CCLs) and CXC ligands
(CXCLs). Among the CCL subfamilies, CCL2 (MCP-1) is present
in the testis at physiologically low levels (Gerdprasert et al., 2002b).
MCP-1 is expressed by Leydig and MPCs and can be regulated by
IL-1, TNF-α, and IFN-β. In response to TLR activation, MCP-1 is
upregulated in SCs (Riccioli et al., 2006). Injection of LPS in vivo
induces elevated MCP-1 levels in the testicular ﬂuid of rats (Gerd-
prasert et al., 2002b), increased MCP-1 levels have been observed
in the testicular ﬂuid of and EAO model (Guazzone et al., 2003).
Among the CXCL subfamilies, CXCL10 is expressed in rat Leydig
cells andupregulatedby IL-1α, TNF-α, and IFN-γ (Huet al., 1998).
In addition, Sendai viruses induce CXCL1 and CXCL10 in rat tes-
ticular macrophages, SCs, Leydig cells, and MPCs (Aubry et al.,
2000). Chemokines are not detected in rat germ cells. Increased
chemokines could facilitate leukocyte inﬁltrations and promote
the inﬂammatory reactions in the testis.
In contrast to inﬂammatory cytokines, IL-10, another anti-
ﬂammatory cytokine, may reduce inﬂammation, autoimmu-
nity, and spermatogenic damages in the mouse model of EAO
(Watanabe et al., 2005). During inﬂammation, testicular resident
macrophages produce IL-10. Production of immunosuppressive
cytokines supports the speculation that testicular immune cells
contribute to the testicular immune privileged status.
CONCLUDING REMARKS
While the testis is a remarkable immune privileged site, chronic
orchitis and autoimmunity are important etiological factors of
male infertility. Further investigation on the immunoregula-
tion of the testis and the link between testicular inﬂammatory
disorders and male infertility will have important implica-
tions for interventions of inﬂammatory disorder-related male
infertility.
Mechanisms underlying testicular immune privilege remain
largely misunderstood. A local innate immune system of the testis
apparently plays an important role in the initiation of the testicular
immune responses. Negative regulation of innate immunity in the
testis must contribute to testicular immune privilege, which could
be the focus of future research. TLR expression and function have
recently been revealed in many testis-speciﬁc cells. These ﬁndings
suggest that both immune cells and local tissue-speciﬁc cells pos-
sess innate immune protective roles against pathogens. Therefore,
local cell-initiated inﬂammatory responses represent a topic that is
worthy of further investigation. Endogenous TLR ligand-triggered
non-infectious inﬂammatory conditions in the testis must be con-
sidered, because a large portion of spermatogenic cells undergo
apoptosis under physiological and pathological conditions, which
may release endogenous TLR ligands if the apoptotic cells are not
removed timely. The manner by which systemic and local inﬂam-
mations impair male fertility is another issue that remains unclear.
Understanding of the fundamental aspects described above may
provide novel insights into the development of prevention and
treatment approaches for testicular inﬂammation-related male
infertility.
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